INTERNATIONAL PATENT: ARBELE LIMITED, LUK, JOHN M. FILES APPLICATION FOR "MULTISPECIFIC ANTIBODY-DRUG CONJUGATES (ADC) TARGETING CDH17-EXPRESSING TUMORS AND METHOD OF MAKING AND USING THEREOF"

GENEVA, March 24 -- ARBELE LIMITED (Unit 522, Biotech Center 2, 11Science Park West Ave.,Shatin, N.T.Hong Kong), LUK, John M. (16425 SE 46TH CT.Bellevue, Washington 98006) filed a patent application (PCT/US2025/046041) for "MULTISPECIFIC ANTIBODY-DRUG CONJUGATES (ADC) TARGETING CDH17-EXPRESSING TUMORS AND METHOD OF MAKING AND USING THEREOF" on Sep 11, 2025. With publication no. WO/2026/060187, the details related to the patent application was published on Mar 19, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): CHOW, Chu Qiao (25B, Block One, Scenery Court, Shatin,Hong Kong), WONG, Po Yee (13...